griffin updates: d-rvd vs rvd in transplant-eligible patients with newly diagnosed multiple myeloma
Published 2 years ago • 154 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
1:05
real-world comparison of rvd vs d-rvd in newly diagnosed transplant-eligible multiple myeloma
-
0:58
dara-rvd in the treatment of hr-smm: an ongoing phase ii trial
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
5:22
updates on german clinical trials in multiple myeloma
-
1:47
real-world outcomes of tandem transplantation in patients with newly diagnosed multiple myeloma
-
10:42
ep 40 - multiple myeloma update jan 2022 - revlimid - zometa side effects - dental work
-
2:41
an overview of the latest advances in hematology
-
2:33
teclistamab approval for multiple myeloma treatment | ross firestone, md, phd | asco 2023
-
3:04
monumental-1 update: talquetamab in r/r multiple myeloma
-
3:27
final survival outcomes from the phase iii optimismm trial: pvd versus vd in r/r myeloma
-
1:18
updates from the monumental-1 trial
-
1:06
derive trial update: did vs dvd in newly diagnosed mm
-
4:45
a first-in-human trial of regn5458 in r/r myeloma: updated phase i data
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
1:10
latest developments in the treatment of emd in myeloma
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
1:30
the use of pirtobrutinib in richter's transformation: data from the bruin trial
-
3:45
update on phase i trial of teclistamab in r/r myeloma
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
1:30
vcdi for multiple myeloma: an update
-
2:33
an update on antibody-based treatment approaches in multiple myeloma